Journals in Health

Cancer Epidemiology

ISSN: 1877-7821
5 Year impact factor: 2.7
Impact factor: 2.4

Cancer determinants, prevention, prognosis and outcomesCancer Epidemiology publishes original research, prioritizing studies that contribute new information about cancer causes, prevention and control. As such, the journal's scope covers all aspects of cancer epidemiology including studies of:• Risk factors for cancer initiation, development, and prognosis • Early detection, prevention, and screening • Survivorship • Descriptive patterns and trends • MethodologyCancer Epidemiology welcomes original articles, reviews (systematic and critical), meta-analyses, invited editorials and commentaries, as well as letters to the editor commenting on research previously published in the journal.Cancer Epidemiology (Cancer Epidemiol.) is indexed and abstracted in: MEDLINE/PubMed, Current Contents/Clinical Medicine, the Science Citation Index Expanded, and Thomson Reuters Journal Citation Reports (Science Edition).

Subscriptions

Cancer Genetics

ISSN: 0165-4608
5 Year impact factor: 1.7
Impact factor: 1.4

The aim of Cancer Genetics is to publish high quality scientific papers on the cellular, genetic and molecular aspects of cancer, including cancer predisposition and clinical diagnostic applications. Specific areas of interest include descriptions of new chromosomal, molecular or epigenetic alterations in benign and malignant diseases; novel laboratory approaches for identification and characterization of chromosomal rearrangements or genomic alterations in cancer cells; correlation of genetic changes with pathology and clinical presentation; and the molecular genetics of cancer predisposition. To reach a basic science and clinical multidisciplinary audience, we welcome original full-length articles, reviews, meeting summaries, brief reports, and letters to the editor.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support CenterCancer Genetics is proud to be affiliated with the Cancer Genomics Consortium.

Subscriptions

Cancer Letters

ISSN: 0304-3835
5 Year impact factor: 8.3
Impact factor: 9.1

An international journal providing a forum for original and pertinent contributions in cancer researchCancer Letters is an international journal that considers full-length articles and Mini Reviews in the broad area of basic and translational oncology. Additionally, Special Issues highlight topical areas in cancer research. Basic areas of interest to a broad readership of Cancer Letters include the molecular genetics and cell biology of cancer, radiation biology, molecular pathology, hormones and cancer, viral oncology, metastasis, and chemoprevention. The journal places emphasis on experimental therapeutics, particularly targeted therapies for personalized cancer medicine, including metronomic chemotherapy.Benefit... to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: https://service.else...

Subscriptions

Cancer Treatment Reviews

ISSN: 0305-7372
5 Year impact factor: 10.9
Impact factor: 9.6

Cancer Treatment Reviews is an international journal that provides state of the art, authoritative review articles to the clinician and researcher to keep them abreast of modern concepts and the latest developments in cancer treatment research.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support CenterJournal of Cancer Treatment Reviews' Inclusion and Diversity PledgeThis journal pledges to maintain diversity on the editorial team. This sits within Elsevier's broader ongoing inclusion & diversity efforts. Equity and inclusion in publishing is critically important for scientific excellence and innovation. We believe passionately in the power of an inclusive publishing environment, not only to do what is right, but to enrich, strengthen and advance us all.

Subscriptions

Cancer Treatment and Research Communications

ISSN: 2213-0896

Cancer Treatment and Research Communications is an international peer-reviewed journal dedicated to providing comprehensive basic, translational, and clinical oncology research. The journal is devoted to articles on detection, diagnosis, prevention, and treatment of cancer and provides a global forum for the nurturing and development of future generations of oncology scientists. Specific areas of interest include basic, translational, and clinical research and mechanistic approaches in all tumor types; cancer biology; molecular carcinogenesis; cancer genetics and genomics; cancer stem cells; molecular and cellular oncology; systems biology; immuno-oncology; chemoprevention strategies; gene and antisense therapy; the pathology of cancer, prognostic and predictive markers; drug sensitivity and resistance and novel treatment strategies to impact patient care. The journal also accepts clinical studies in oncology, with an emphasis on prospective early phase clinical trials.Our mission is to be the premier source of relevant information through promoting excellence in research and facilitating the timely translation of that science to health care and clinical practice. Peer reviewed types of articles include Original Reports, Reviews and Editorials. The journal will not consider Case Reports or articles related to Cancer Policy.

Subscriptions

Cancer Treatment and Research Communications

ISSN: 2468-2942

Subscriptions

Cardiac Electrophysiology Clinics

ISSN: 1877-9182

Cardiac Electrophysiology Clinics provides you with practical, hands-on advice on the evaluation and management of patients with heart rhythm disorders. Each issue provides expert, state-of-the-art discussions on a single topic relevant to your practice. You'll find clear, comprehensive coverage on valuable topics such as sudden cardiac death, diagnostic evaluation of arrhythmias, advances in arrhythmia analysis, arrhythmias in special populations, antiarrhythmic drug therapy, cardiac pacing and defibrillation, genetics and pharmacogentics, and much more. Cardiac Electrophysiology Clinics is published four times a year—March, June, September, and December.

Subscriptions

Cardiology Clinics

ISSN: 0733-8651
5 Year impact factor: 2.3
Impact factor: 2.6

Published four times a year—in February, May, August, and November— Cardiology Clinics updates you on the latest trends in patient management, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Tailored to meet the needs of those in the field of cardiology, each issue focuses on a single cardiology topic, including acute coronary syndromes/cardiac emergencies, coronary artery disease, heart failure, heart rhythm disorders, and much more.

Subscriptions

Cardiovascular Pathology

ISSN: 1054-8807
5 Year impact factor: 2
Impact factor: 2.3

A Journal of Basic, Clinical and Applied Cardiovascular Science The Official Journal of the Society for Cardiovascular PathologyCardiovascu... Pathology is a bimonthly journal that presents articles on topics covering the entire spectrum of cardiovascular disease. The Journal's primary objective is to publish papers on disease-oriented morphology and pathogenesis from clinicians and scientists in the cardiovascular field. Subjects covered include cardiovascular biology, prosthetic devices, molecular biology and experimental models of cardiovascular disease.For more information about the Society for Cardiovascular Pathology (SCVP), please visit their website at URL: http://scvp.net.

Subscriptions

Cardiovascular Revascularization Medicine

ISSN: 1553-8389
5 Year impact factor: 1.5
Impact factor: 1.6

including Molecular Interventions Cardiovascular Revascularization Medicine (CRM) is an international, English-language, multidisciplinary, peer-reviewed journal that publishes original laboratory and clinical investigations related to revascularization therapies in cardiovascular medicine. CRM publishes 12 regular print issues and a supplemental issue each year.The journal is indexed on Index Medicus and MEDLINE®/PubMed®.The journal's location in Washington, DC, gives it an advantage in reporting on regulatory issues as they pertain to interventional cardiology and structural heart disease. The journal is read by cardiologists, interventional cardiologists, structural heart interventionalists, vascular physicians, healthcare regulators, industry, fellows in training, and innovators around the globe.CRM is also the official journal of the Cardiovascular Research Technologies (CRT) meeting, a premier event that brings together about 3,000 interventional cardiologists annually to discuss cutting-edge research and innovations. Attendees are encouraged to submit papers based on abstracts, interesting cases, late-breaking trials, and innovations presented at the meeting that impact interventional cardiologists' practice. The journal structures its content to reflect topics based on each track of the CRT meeting: Complex Coronary, Valve and Structural, Endovascular, Imaging and Physiology, Atherosclerosis, Cardiogenic Shock, Technology and Innovation, Regulatory and Healthcare Policy, and Innovations.CRM publishes articles related to preclinical and clinical work, including pharmacological interventions, and restenosis management; and treatment, including experiments conducted in human subjects, laboratory animals, and in vitro. Specific areas of interest include percutaneous angioplasty in coronary and peripheral arteries, intervention in structural heart disease, cardiovascular surgery, congenital heart disease, coronary heart disease, genetics and translational science, health services and outcomes research, invasive imaging, regulatory and health policy, technology and innovation, and vascular medicine.The journal's nearest competitors are JACC: Cardiovascular Interventions, Circulation: Cardiovascular Interventions, and EuroIntervention.CRM will consider all articles describing clinical trials and translational research (i.e., those that unite the clinic with the laboratory). The journal publishes original articles, research letters, reviews, editorials, and special features. Original articles that address any aspect of cardiovascular revascularization or structural intervention are invited. Letters to the editor, trial design papers, and interesting images are encouraged. The journal's peer-review process is single-blind.

Subscriptions

Related subjects

Dentistry

Health professions

Medicine

Nursing and midwifery

Veterinary science and veterinary medicine

Life Sciences

Physical Sciences & Engineering

Social Sciences & Humanities

Health

Journals in Health

Cancer Epidemiology

Cancer Genetics

Cancer Letters

Cancer Treatment Reviews

Cancer Treatment and Research Communications

Cancer Treatment and Research Communications

Cardiac Electrophysiology Clinics

Cardiology Clinics

Cardiovascular Pathology

Cardiovascular Revascularization Medicine

Related subjects